Mark J. Millan - Concepedia

Author

Mark J. Millan

Also Known As

M J Clemente Millán, M J MILLAN, M J Millan, M MILLAN, M Millan, M. J. MILLAN, M. J. Millan, M. Millan, M.J MILLAN, M.J Millan

382

Publications

26.4K

Citations

H-Index

156

Concepts

All Affiliations

Servier (France)AVL (France)Centre National de la Recherche Scientifique Inserm Karolinska Institutet

About

Mark J. Millan is an author at Servier (France) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	138	7.6K
2	Health Sciences	19	30	1.2K
3	Natural Sciences	4	4	173
4	Public Health	4	4	159
5	Engineering	1	1	42

Mark J. Millan

198

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways Mark J. Millan, Alain P. Gobert, F. Lejeune, Journal of Pharmacology and Experimental Therapeutics	2003	509
Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat Alain P. Gobert, Jean‐Michel Rivet, F. Lejeune, Synapse PsychopharmacologyAntagonist Mdl100,907Social SciencesDialysis ApproachCombined Dialysis	2000	335
Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment Mark J. Millan, K.C.F. Fone, Thomas Steckler, European Neuropsychopharmacology	2014	334
Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo Mark J. Millan, Anne Dekeyne, Alain P. Gobert Neuropharmacology NeuropsychologyNeurophysiologyMedicineNeurotransmitterPsychopharmacology	1998	282
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade Mark J. Millan, Mauricette Brocco, Alain P. Gobert, Psychopharmacology PsychiatryMedicineAnxiolytic PropertiesPsychopharmacology5-Ht2c Receptor Blockade	2004	244
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain Anne Amphoux, Vincent Vialou, Eva Drescher, Neuropharmacology Molecular PharmacologyPharmacological StudyDifferential PharmacologicalNeurophysiologyMedicine	2006	210
Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release Alain P. Gobert, Jean‐Michel Rivet, Valérie Audinot, Neuroscience Neurobiological MechanismPsychiatryNeurophysiologyNeurotransmitterNeuroendocrine Mechanism	1998	203
Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat Mark J. Millan, Andrzej Członkowski, Brian Morris, Pain Right Hind PawAcute PainPain MedicineVentral HornNeuropathic Pain	1988	197
Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes Adrian Newman‐Tancredi, Didier Cussac, Yann Quentric, Journal of Pharmacology and Experimental Therapeutics	2002	192
Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex Pascal Fossat, Fabrice Turpin, Silvia Sacchi, Cerebral Cortex NeuropsychologyPrefrontal CortexSynaptic TransmissionSynaptic NmdarsNeurotransmitter	2011	184

Page 1